Intriguingly, CCA cells exhibited heightened sensitivity to ceritinib compared to non-CCA cells, despite their low level of or absence of ALK expression as evidenced by data mining in the CCLE and TCGA databases and silencing of ALK, respectively (Figure 1D–L). Here, ALK is linked to cholangiocarcinoma.